Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 67.11B | 67.73B | 56.79B | 49.98B | 44.06B | 50.77B |
Gross Profit | 16.84B | 16.35B | 13.40B | 11.87B | 11.07B | 12.76B |
EBITDA | 6.13B | 7.30B | 5.50B | 4.69B | 5.18B | 6.11B |
Net Income | 3.22B | 3.60B | 2.48B | 1.52B | 2.38B | 2.51B |
Balance Sheet | ||||||
Total Assets | 70.29B | 69.39B | 60.16B | 54.30B | 53.24B | 51.25B |
Cash, Cash Equivalents and Short-Term Investments | 20.35B | 18.94B | 18.02B | 14.77B | 14.25B | 12.06B |
Total Debt | 5.34B | 5.75B | 5.53B | 5.15B | 4.94B | 5.04B |
Total Liabilities | 23.51B | 25.07B | 21.12B | 18.77B | 18.56B | 18.46B |
Stockholders Equity | 43.94B | 41.56B | 36.65B | 33.39B | 31.97B | 30.23B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 3.95B | 3.06B | 988.00M | 3.35B | 1.53B |
Operating Cash Flow | 0.00 | 5.33B | 4.17B | 2.10B | 4.32B | 3.76B |
Investing Cash Flow | 0.00 | -3.90B | -2.51B | -1.46B | -1.81B | -1.87B |
Financing Cash Flow | 0.00 | -1.70B | -482.00M | -1.69B | -574.00M | -1.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥23.50B | 8.21 | 2.71% | 3.37% | -21.94% | ||
73 Outperform | ¥20.11B | 7.02 | 4.70% | 7.61% | -32.07% | ||
72 Outperform | ¥28.06B | 8.36 | 5.32% | -0.98% | 26.26% | ||
71 Outperform | ¥15.46B | 7.30 | 7.39% | -3.83% | 4.11% | ||
65 Neutral | $10.75B | 15.65 | 5.18% | 1.92% | 3.09% | -27.41% | |
63 Neutral | ¥24.66B | 16.89 | 3.47% | 5.69% | 202.27% | ||
59 Neutral | ¥7.23B | 19.70 | 3.03% | 0.66% | 41.70% |